His primary scientific interests are in Internal medicine, Endocrinology, Steatohepatitis, Fatty liver and Steatosis. His research is interdisciplinary, bridging the disciplines of Gastroenterology and Internal medicine. His study focuses on the intersection of Endocrinology and fields such as Microsome with connections in the field of Alcoholic liver disease and Lipid peroxidation.
The various areas that he examines in his Steatohepatitis study include Inflammation, Nonalcoholic fatty liver disease, Liver injury and Downregulation and upregulation. His work deals with themes such as Diabetes mellitus, Obesity, Type 2 diabetes, Metabolic syndrome and Bile acid, which intersect with Fatty liver. His Steatosis study combines topics in areas such as Adipose tissue, CYP2E1, Leptin and Lipotoxicity.
His primary areas of investigation include Internal medicine, Endocrinology, Fatty liver, Gastroenterology and Steatohepatitis. His study in Cirrhosis, Steatosis, Liver disease, Insulin resistance and Hepatitis C is done as part of Internal medicine. Geoffrey C. Farrell usually deals with Endocrinology and limits it to topics linked to Microsome and Cytochrome.
His Fatty liver study integrates concerns from other disciplines, such as Diabetes mellitus, Metabolic syndrome and Lipotoxicity. His Gastroenterology research includes themes of Liver biopsy, Hepatocellular carcinoma, Non alcoholic and Surgery. His studies in Steatohepatitis integrate themes in fields like Fibrosis, Inflammation, Lipogenesis and Lipid peroxide.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Fatty liver, Steatohepatitis and Steatosis. His Internal medicine study combines topics in areas such as Gastroenterology and Type 2 diabetes. His work in Fatty liver addresses issues such as Inflammation, which are connected to fields such as Reperfusion injury and Peroxisome proliferator-activated receptor.
His research integrates issues of Fibrosis, Hepatocellular carcinoma, Atorvastatin and Immunology in his study of Steatohepatitis. Geoffrey C. Farrell has included themes like Nonalcoholic fatty liver disease and Cytokine in his Steatosis study. His study in Cirrhosis is interdisciplinary in nature, drawing from both Liver cancer, Liver disease, Hepatitis C and Liver transplantation.
Geoffrey C. Farrell mainly focuses on Internal medicine, Endocrinology, Steatohepatitis, Fatty liver and Steatosis. The Internal medicine study combines topics in areas such as Gastroenterology and Type 2 diabetes. Geoffrey C. Farrell studied Endocrinology and Downregulation and upregulation that intersect with Rosiglitazone and Hepatocyte growth factor.
The study incorporates disciplines such as Fibrosis, Liver disease, Cirrhosis and Hepatocellular carcinoma in addition to Steatohepatitis. Geoffrey C. Farrell combines subjects such as Inflammation, Inflammasome, Immunology and Liver injury with his study of Fatty liver. As a part of the same scientific study, he usually deals with the Steatosis, concentrating on Cytokine and frequently concerns with Pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
Geoffrey C. Farrell;Claire Z. Larter.
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Yun-Fan Liaw;Joseph J Y Sung;Wan Cheng Chow;Geoffrey Farrell.
The New England Journal of Medicine (2004)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi.
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
Shivakumar Chitturi;Shehan Abeygunasekera;Geoffrey C. Farrell;Jane Holmes-Walker.
Beyond Insulin Resistance in NASH: TNF-alpha or Adiponectin?
Jason M. Hui;Alex Hodge;Geoffrey C. Farrell;James G. Kench.
Epidemiology of non-alcoholic fatty liver disease in China
Jian-Gao Fan;Jian-Gao Fan;Geoffrey C. Farrell.
Journal of Hepatology (2009)
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Jason M Hui;Archana Sud;Geoffrey C Farrell;Priyanka Bandara.
Etiopathogenesis of Nonalcoholic Steatohepatitis
Shivakumar Chitturi;Geoffrey C. Farrell.
Seminars in Liver Disease (2001)
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Isabelle A. Leclercq;Geoffrey C. Farrell;Jaqueline Field;David R. Bell.
Journal of Clinical Investigation (2000)
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Martin D. Weltman;Geoffrey C. Farrell;Pauline Hall;Magnus Ingelman‐Sundberg.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: